Sinotherapeutics Inc
SSE:688247
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinotherapeutics Inc
SSE:688247
|
CN |
|
Kontoor Brands Inc
NYSE:KTB
|
US |
|
O
|
Origin Bancorp Inc
NYSE:OBK
|
US |
|
RNI Negocios Imobiliarios SA
BOVESPA:RDNI3
|
BR |
|
S
|
Salomon A Angel Ltd
TASE:ANGL
|
IL |
|
N
|
Namib Minerals
NASDAQ:NAMM
|
KY |
|
A
|
Aoki Super Co Ltd
TSE:9977
|
JP |
|
CSI Solar Co Ltd
SSE:688472
|
CN |
|
Harmony Biosciences Holdings Inc
NASDAQ:HRMY
|
US |
|
S
|
ScandBook Holding AB
STO:SBOK
|
SE |
|
SKY Perfect JSAT Holdings Inc
TSE:9412
|
JP |
|
P
|
Punit Commercials Ltd
BSE:512099
|
IN |
|
Bionano Genomics Inc
NASDAQ:BNGO
|
US |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
CN |
|
China Ecotek Corp
TWSE:1535
|
TW |
|
T
|
Titan America SA
NYSE:TTAM
|
BE |
|
Auxico Resources Canada Inc
OTC:AUXIF
|
CA |
|
Keppel REIT
SGX:K71U
|
SG |
|
Packaging Corp of America
NYSE:PKG
|
US |
|
P
|
Partner Communications Company Ltd
TASE:PTNR
|
IL |
|
Stoneridge Inc
NYSE:SRI
|
US |
Relative Value
The Relative Value of one Sinotherapeutics Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 9.72 CNY, Sinotherapeutics Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Sinotherapeutics Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Sinotherapeutics Inc
SSE:688247
|
4.4B CNY | 9.2 | 44.7 | 48 | 48 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |